Rhythm Pharmaceuticals, Inc. (RYTM) Stock

Rhythm Pharmaceuticals, Inc. (RYTM) is a Healthcare stock trading at $96.81 (as of 2026-06-18), with a market capitalization of $6.05B and a trailing P/E of -28.7. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Rhythm Pharmaceuticals, Inc. develops and commercializes therapeutics for rare genetic obesity disorders. Its lead product, IMCIVREE, targets melanocortin-4 receptor–related conditions, and it is also developing setmelanotide for multiple obesity indications linked to POMC/LEPR and other MC4R pathway disorders.

Valuation — source: SEC EDGAR (first-party)
Price$96.81
Market Cap$6.05B
P/E Ratio-28.7
EV / EBITDA-31.5
Price / Book50.02
Price / Sales28.31
DCF Value (model)$-29.87
DCF Upside vs Price-130.9%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$189.76M
Net Margin-103.6%
Return on Equity-164.9%
Debt / Equity0.88
Current Ratio4.17
Revenue Growth (YoY)45.8%
EPS Growth (YoY)-28.3%
FCF Growth (YoY)2.4%
Financial Health — source: SEC EDGAR
Altman Z-Score7.66 (safe)
Piotroski F-Score6/9 (moderate)
Valuation vs Sector & Industry
Stock P/E-28.7
Sector P/E (Healthcare)21.0
Industry P/E (Pharmaceutical Products)17.3
vs Sector-236.7%
vs Industry-266.0%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderVANGUARD GROUP INC ($664.82M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryPharmaceutical Products
CEODavid Meeker
Employees283
CountryUS
IPO Date2017-10-09

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • Halozyme Therapeutics, Inc. (HALO)
  • Cytokinetics, Incorporated (CYTK)
  • Praxis Precision Medicines, Inc. (PRAX)
  • Nuvalent, Inc. (NUVL)
  • Krystal Biotech, Inc. (KRYS)
  • Kymera Therapeutics, Inc. (KYMR)
  • PTC Therapeutics, Inc. (PTCT)
  • Vaxcyte, Inc. (PCVX)
RYTM earnings history · RYTM institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.